U.S. Patent Disclosures
Wednesday, June 6, 2012
Durect Corp., of Cupertino, Calif., and Pain Therapeutics Inc., of Austin, Texas, were issued four patents relating to their Oradur technology, Remoxy (oxycodone) Extended-Release Capsules CII and other Oradur-based opioids.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.